Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis
Jacqueline Burré,Robert H Edwards,Glenda Halliday,Anthony E Lang,Hilal A Lashuel,Ronald Melki,Shigeo Murayama,Tiago F Outeiro,Stella M Papa,Leonidas Stefanis,Amanda L Woerman,Dalton James Surmeier,Lorraine V Kalia,Ryosuke Takahashi,MDS Scientific Issues Committee,Abby Olsen,Ece Bayram,Han-Lin Chaing,Jee Young Lee,Kathryn Peall,Katja Lohmann,Kirsten Zeuner,Lorraine Kalia,Mario Cornejo-Olivas,Paolo Calabresi,Serge Przedborski
DOI: https://doi.org/10.1002/mds.29897
Abstract:Various forms of Parkinson's disease, including its common sporadic form, are characterized by prominent α-synuclein (αSyn) aggregation in affected brain regions. However, the role of αSyn in the pathogenesis and evolution of the disease remains unclear, despite vast research efforts of more than a quarter century. A better understanding of the role of αSyn, either primary or secondary, is critical for developing disease-modifying therapies. Previous attempts to hone this research have been challenged by experimental limitations, but recent technological advances may facilitate progress. The Scientific Issues Committee of the International Parkinson and Movement Disorder Society (MDS) charged a panel of experts in the field to discuss current scientific priorities and identify research strategies with potential for a breakthrough. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.